Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore

News

Stay up to date on the latest crypto trends with our expert, in-depth coverage.

banner
All
Crypto
Stocks
Commodities & Forex
Macro
Flash
20:06
Zenas BioPharma Inc. recently announced that the proceeds from its financing will be specifically used to support the commercialization preparations of its core product, Obexelimab, in the US market.
In addition, part of the funds will also be used to further expand the company’s R&D pipeline, as well as for other general corporate operating purposes.
20:06
Wrap Technologies Inc. is accelerating its growth momentum and has set an ambitious goal of achieving 100% revenue growth by 2026.
At the same time, the company announced its financial results for the fourth quarter and the entire fiscal year of 2025.
20:05
In a recent filing with the U.S. Securities and Exchange Commission, Riverview Bancorp Inc disclosed a significant asset disposal action.
After completing its portfolio reclassification, the company has sold securities assets totaling 149.3 million USD, with a preliminary estimate of approximately 11.4 million USD in pre-tax losses. This transaction marks an important step in Riverview's strategic adjustment of its balance sheet. The decision to sell the securities arose from the company's prudent assessment of the current market environment and aims to optimize the asset allocation structure. Although this disposal results in short-term financial losses, it may create more favorable conditions for future capital flexibility and risk management. Market analysts point out that timely adjustments of securities portfolios by financial institutions are common risk management practices. By accepting controllable book losses, Riverview may be paving the way to mitigate interest rate fluctuations and enhance capital use efficiency. The specific details and subsequent impact of this transaction will be further clarified in the company's upcoming quarterly financial report.
News